Octave Bioscience Home | Octave Bioscience

THE NEED IS REAL

To dramatically improve outcomes we need to improve management.
To improve management, we first need to improve measurement.

That’s what Octave is here to do.

THE MISSION

The challenges for multiple sclerosis are significant, the issues are overwhelming, and the needs are mostly unmet. That’s why Octave is creating a comprehensive, measurement driven Care Management Platform for MS.

THE PROBLEM

MS is a chronic, debilitating, high cost disease with variable outcomes.

THE BIG PICTURE ABOUT MULTIPLE SCLEROSIS

STRIKES EARLY

Late 20’s average onset, affects 3:1 women to men

CHRONIC DISEASE

Long term costs include medical, drug, ancillaries and disability

PROGRESSIVE

Symptom burden and co-morbidities impact employment

MULTIPLE OPTIONS

Varied mechanisms, efficacy, side effects and tolerability

HIGH COST

$60-80,000 per year, over $14B spend, with unguided use

MS disease course is driven by inflammation, demyelination and axonal damage. Yet, the tools to assess these are subjective, qualitative and inadequate.

THE SOLUTION STARTS WITH MEASUREMENT

Biology is closest to truth

Octave will provide the first blood test to accurately measure disease activity at the biology level to personalize patient decision making.

Life happens between office visits

Octave will capture high resolution data using sensors, wearables and mobile tools to identify changes in disease status and alert care teams.

MRIs can be improved upon

Octave will enhance and optimize images adding quantitation, serial trends and contextualization to improve information quality.

Octave integrates these measurement data streams into a comprehensive set of insights.

THIS PROVIDES FOR BETTER MANAGEMENT

Stakeholders need better information that is highly actionable.

Octave’s three layer model of biological, clinical and economic data combined with sophisticated analytics, contextualization, machine learning and AI provide new insights for Physicians, Patients, Payers, and Pharma.